Filing Details
- Accession Number:
- 0000950170-25-038834
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-13 16:46:51
- Reporting Period:
- 2025-03-12
- Filing Date:
- 2025-03-13
- Accepted Time:
- 2025-03-13 16:46:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1111485 | Rxsight Inc. | RXST | Ophthalmic Goods (3851) | 943268801 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1902243 | Tamara Fountain | C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-12 | 7,000 | $25.71 | 24,793 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.